Saras SpA (SRS):石油・ガス:M&Aディール及び事業提携情報

◆英語タイトル:Saras SpA (SRS) - Oil & Gas - Deals and Alliances Profile
◆商品コード:DATA904C8736
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:石油・ガス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Saras SpA (Saras) is crude oil refiner and operates refining, marketing, power generation and wind power businesses. The company’s major refinery is Sarroch refinery, on the Southwestern coast of Sardinia. Saras is also active in the production and sale of electricity, and offers industrial engineering, scientific research, and information technology services. The company also offers following services and solutions to oil sector including environmental quality control, engineering services and plant packages, process control solutions, environmental engineering solutions and chemical research services. It has operational presence in Saras is headquartered in Sarroch, Italy.

Saras SpA (SRS) – Oil & Gas – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Oil & Gas eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Saras SpA, Oil & Gas, Deals By Year, 2012 to YTD 2018 5
Saras SpA, Oil & Gas Deals By Type, 2012 to YTD 2018 6
Saras SpA, Oil & Gas, Deals By Region, 2012 to YTD 2018 7
Saras SpA, Oil & Gas, Deals By Sector, 2012 to YTD 2018 8
Saras SpA, Oil & Gas, Deals Summary, 2012 to YTD 2018 9
Saras SpA, Oil & Gas, Deal Details 10
Asset Purchase 10
Sarlux Completes Acquisition Of Processing Units In Sarroch Refinery, Italy From Versalis For US$60.9 Million 10
Partnerships 11
Rosneft Forms Joint Venture With Saras 11
Debt Offering 12
Saras Announces Private Placement Of 1.7% Bonds, Due 2022 For US$237.4 Million 12
Saras Completes Private Placement Of 5% Bonds For US$238 Million 13
Acquisition 14
Massimo And MOBRO Sell 10% Stake In Saras For US$220.2 Million 14
Rosneft Completes Sale Of Remaining 12% Stake In Saras For US$186.1 Million 16
Rosneft Sells 8.99% Stake In Saras For US$184.2 Million 18
Rosneft Completes Acquisition Of 7.29% Stake In Saras For US$124.5 Million 20
Rosneft Completes Acquisition Of 13.7% Stake In Saras, Integrated Energy Company, For US$234 Million 21
Saras SpA – Key Competitors 23
Saras SpA – Key Employees 24
Saras SpA – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Jul 30, 2018: Board of directors of SARAS approves half-year financial report as of 30th June 2018 26
Mar 12, 2018: Saras Board Of Director Approved Draft Financial Statements As Of 31st December 2017 Group Consolidated Financial Statements And Business Plan 2018 – 2021 29
May 16, 2017: Board Of Directors Of SARAS Approves Interim Financial Report As Of 31st March 2017 41
Other Significant Developments 44
Sep 19, 2018: Fire at the Sarroch refinery contained 44
May 14, 2018: Board Of Directors Of SARAS Approves Interim Financial Report As Of 31st March 2018 45
Sep 23, 2017: Iranian Crude Oil Exports Mounting As Joint Fields Get Boost 46
May 03, 2017: Rosneft Oil Provides Operating Results For Q1 2017 47
Mar 26, 2017: NOC Warns Oil Market Against Illegal Contracts 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51

List of Tables
Saras SpA, Oil & Gas, Key Facts, 2017 2
Saras SpA, Oil & Gas, Deals Summary, 2012 to YTD 2018 2
Saras SpA, Oil & Gas, Deals By Year, 2012 to YTD 2018 5
Saras SpA, Oil & Gas Deals By Type, 2012 to YTD 2018 6
Saras SpA, Oil & Gas, Deals By Region, 2012 to YTD 2018 7
Saras SpA, Deals By Sector, 2012 to YTD 2018 8
Saras SpA, Oil & Gas, Deals Summary, 2012 to YTD 2018 9
Sarlux Completes Acquisition Of Processing Units In Sarroch Refinery, Italy From Versalis For US$60.9 Million 10
Rosneft Forms Joint Venture With Saras 11
Saras Announces Private Placement Of 1.7% Bonds, Due 2022 For US$237.4 Million 12
Saras Completes Private Placement Of 5% Bonds For US$238 Million 13
Massimo And MOBRO Sell 10% Stake In Saras For US$220.2 Million 14
Rosneft Completes Sale Of Remaining 12% Stake In Saras For US$186.1 Million 16
Rosneft Sells 8.99% Stake In Saras For US$184.2 Million 18
Rosneft Completes Acquisition Of 7.29% Stake In Saras For US$124.5 Million 20
Rosneft Completes Acquisition Of 13.7% Stake In Saras, Integrated Energy Company, For US$234 Million 21
Saras SpA, Key Competitors 23
Saras SpA, Key Employees 24
Saras SpA, Other Locations 25
Saras SpA, Subsidiaries 25

List of Figures
Saras SpA, Oil & Gas, Deals by Type, 2012 to YTD 2018 2
Saras SpA, Oil & Gas, Deals By Year, 2012 to YTD 2018 2
Saras SpA, Oil & Gas, Deals By Region, 2012 to YTD 2018 2
Saras SpA, Oil & Gas, Deals By Sector, 2012 to YTD 2018 2
Saras SpA, Oil & Gas, Deals By Year, 2012 to YTD 2018 5
Saras SpA, Oil & Gas, Deals by Type, 2012 to YTD 2018 6
Saras SpA, Oil & Gas, Deals By Region, 2012 to YTD 2018 7
Saras SpA, Oil & Gas, Deals by Sector, 2012 to YTD 2018 8

★海外企業調査レポート[Saras SpA (SRS):石油・ガス:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Teijin Limited:企業のM&A・事業提携・投資動向
    Teijin Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Teijin Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • NTT Communications Corporation:企業の戦略・SWOT・財務情報
    NTT Communications Corporation - Strategy, SWOT and Corporate Finance Report Summary NTT Communications Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Hawaiian Holdings, Inc.:企業の戦略・SWOT・財務情報
    Hawaiian Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hawaiian Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • IntraPace Inc:医療機器:M&Aディール及び事業提携情報
    Summary IntraPace Inc (IntraPace) is a medical device company that develops novel implantable systems. The company offers abiliti systems that contain sensors intended to track consumption events and physical activity to direct when therapy is delivered and to monitor a patient's progress toward wei …
  • BellBrook Labs LLC-医療機器分野:企業M&A・提携分析
    Summary BellBrook Labs LLC (BellBrook) is a medical device company that develops detection reagents and screening tools. The company’s biochemical assay technology offers UVO microconduit array platform, chemotaxis assay plate, transcreener HTS assays, ADP² assays, AMP² and GMP² assays, GDP assays, …
  • Tonix Pharmaceuticals Holding Corp (TNXP):企業の財務・戦略的SWOT分析
    Summary Tonix Pharmaceuticals Holding Corp (Tonix) is a developer of pharmaceutical products to address public health challenges. The company offers pharmaceutical products and treatments for disorders of the central nervous system including fibromyalgia, post traumatic stress disorder and episodic …
  • Jubilant Biosys Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Jubilant Biosys Ltd (Jubilant Biosys), a subsidiary of Jubilant Life Sciences Ltd, is a provider of drug discovery and development solutions. The company offers functional discovery services such as toxicology models, computational chemistry, medicinal chemistry, structural biology, drug met …
  • OJSC Dixy Group:企業の戦略・SWOT・財務情報
    OJSC Dixy Group - Strategy, SWOT and Corporate Finance Report Summary OJSC Dixy Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • National Company KazMunayGas:企業の戦略的SWOT分析
    National Company KazMunayGas - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Guangxi Investment Group Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Guangxi Investment Group Co Ltd (Guangxi Investment) is a diversified company. The company’s business segments include energy, aluminium, financial, cultural tourism, international business and medical and medical health business. Its energy business provides investments in the construction …
  • OBI Pharma Inc (4174):製薬・医療:M&Aディール及び事業提携情報
    Summary OBI Pharma Inc (OBI Pharma) is a biopharmaceutical company that develops therapies for the treatment of cancer and infectious diseases. The company’s products include adagloxad simolenin, an active immunotherapy which is intended for the treatment of metastatic breast cancer; and OBI-833, a …
  • Jiangsu Kanion Pharmaceutical Co Ltd (600557):製薬・医療:M&Aディール及び事業提携情報
    Summary Jiangsu Kanion Pharmaceutical Co Ltd (Jiangsu Kanion) is a developer, producer and marketer of concentrated drugs. The company offers products in the therapeutic areas of orthopedics, cardiovascular, gynecology, antitumor, anti-infective, and others. It also offers products for fever, headac …
  • Export Development Bank Of Egypt:企業の戦略・SWOT・財務情報
    Export Development Bank Of Egypt - Strategy, SWOT and Corporate Finance Report Summary Export Development Bank Of Egypt - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Aarti Drugs Ltd (AARTIDRUGS):企業の財務・戦略的SWOT分析
    Summary Aarti Drugs Ltd (ADL), a subsidiary of Aarti Group of Industries is a contract manufacturer of pharmaceutical products that offers therapeutic products, ingredients, bulk drugs, and chemicals. The company's products include active pharmaceutical ingredients, pharma intermediates, and special …
  • Besso Insurance Group Limited:企業の戦略・SWOT・財務情報
    Besso Insurance Group Limited - Strategy, SWOT and Corporate Finance Report Summary Besso Insurance Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • MannKind Corp (MNKD)-製薬・医療分野:企業M&A・提携分析
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that discovers, develops and commercializes therapeutic products to treat diseases such as diabetes. The company’s lead product, Afrezza is a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type …
  • TETRA Technologies Inc (TTI):石油・ガス:M&Aディール及び事業提携情報
    Summary TETRA Technologies Inc (TETRA) is an oil and gas company that offers completion fluids and associated products and services. The company’s services comprise compression services, fluid, filtration and tools services, offshore services, production testing, rig cooling services, technology cen …
  • Scottish Power Ltd:企業の発電所・SWOT分析2018
    Scottish Power Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Med BioGene Inc (MBI)-医療機器分野:企業M&A・提携分析
    Summary Med BioGene Inc (Med BioGene) is a life sciences company, which develops and commercializes genome-based clinical laboratory diagnostic tests. The company’s lead test under development, GeneFx Lung formerly LungExpress Dx, is a proprietary gene expression based test. Its GeneFx Lung test is …
  • Herantis Pharma Plc (HRTIS):企業の財務・戦略的SWOT分析
    Summary Herantis Pharma Plc (Herantis Pharma) is a drug development company that offers regenerative medicine for neurodegenerative diseases. The company's pipeline products include CDNF for amyotrophic lateral sclerosis, CDNF for Parkinson’s disease and lymfactin for secondary lymphedema. Its lymfa …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆